Your browser doesn't support javascript.
loading
POSNOC-POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodes.
Goyal, Amit; Mann, G Bruce; Fallowfield, Lesley; Duley, Lelia; Reed, Malcolm; Dodwell, David; Coleman, Robert E; Fakis, Apostolos; Newcombe, Robert; Jenkins, Valerie; Whitham, Diane; Childs, Margaret; Whynes, David; Keeley, Vaughan; Ellis, Ian; Fairbrother, Patricia; Sadiq, Shabina; Monson, Kathryn; Montgomery, Alan; Tan, Wei; Vale, Luke; Homer, Tara; Badger, Heath; Haines, Rachel Helen; Lewis, Mickey; Megias, Daniel; Nabi, Zohal; Singh, Preetinder; Caraman, Andrei; Miles, Elizabeth.
Affiliation
  • Goyal A; Department of Surgery, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK amit.goyal@nhs.net.
  • Mann GB; Department of Surgery, The University of Melbourne, Melbourne, Victoria, Australia.
  • Fallowfield L; Breast Cancer Trials, Newcastle, New South Wales, Australia.
  • Duley L; Sussex Health Outcomes Research & Education in Cancer (SHORE-C), Brighton & Sussex Medical School, University of Sussex, Brighton, UK.
  • Reed M; Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK.
  • Dodwell D; Brighton and Sussex Medical School, Brighton, UK.
  • Coleman RE; Nuffield Department of Population Health, Oxford University, Oxford, UK.
  • Fakis A; Department of Oncology and Metabolism, Weston Park Hospital, Sheffield, UK.
  • Newcombe R; Research and Development, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK.
  • Jenkins V; Department of Primary Care and Public Health, Cardiff University, Cardiff, UK.
  • Whitham D; Sussex Health Outcomes Research & Education in Cancer (SHORE-C), Brighton & Sussex Medical School, University of Sussex, Brighton, UK.
  • Childs M; Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK.
  • Whynes D; Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK.
  • Keeley V; School of Economics, University of Nottingham, Nottingham, UK.
  • Ellis I; Lymphoedema Department, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK.
  • Fairbrother P; School of Medicine, University of Nottingham, Nottingham, UK.
  • Sadiq S; Patient Advocate, Independent Cancer Patients' Voice, London, UK.
  • Monson K; Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK.
  • Montgomery A; Sussex Health Outcomes Research & Education in Cancer (SHORE-C), Brighton & Sussex Medical School, University of Sussex, Brighton, UK.
  • Tan W; Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK.
  • Vale L; Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK.
  • Homer T; Health Economics Group, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Badger H; Health Economics Group, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Haines RH; Breast Cancer Trials, Newcastle, New South Wales, Australia.
  • Lewis M; Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK.
  • Megias D; Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK.
  • Nabi Z; National Radiotherapy Trials Quality Assurance Group, Mount Vernon Cancer Centre, Northwood, UK.
  • Singh P; National Radiotherapy Trials Quality Assurance Group, Mount Vernon Cancer Centre, Northwood, UK.
  • Caraman A; National Radiotherapy Trials Quality Assurance Group, Mount Vernon Cancer Centre, Northwood, UK.
  • Miles E; National Radiotherapy Trials Quality Assurance Group, Mount Vernon Cancer Centre, Northwood, UK.
BMJ Open ; 11(12): e054365, 2021 12 02.
Article in En | MEDLINE | ID: mdl-34857578

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Clinical_trials / Guideline / Qualitative_research Aspects: Ethics / Patient_preference Limits: Female / Humans Language: En Journal: BMJ Open Year: 2021 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Clinical_trials / Guideline / Qualitative_research Aspects: Ethics / Patient_preference Limits: Female / Humans Language: En Journal: BMJ Open Year: 2021 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom